Gian Lifecare — 360° view

Gian Lifecare, a company in the Healthcare Service Provider industry, reported revenue of ₹1.12 crore and net profit of ₹0.10 crore for the December 2025 quarter.

Gian Lifecare (BSE: GIANLIFE) closed at ₹4.29 on 20 Nov 2026, down 64.8% over the past year. Its market capitalisation is ₹4 crore.

Share price
₹4.29 (20 Nov 2026)
Market cap
₹4 Cr (20 Nov 2026)
Revenue
₹1 Cr (December 2025 quarter)
Net profit
₹0 Cr (December 2025 quarter)
ROCE
2.40% (FY25)
ROE
-0.21% (FY25)
Book value
₹18.2 (FY25)
Dividend yield
0.00% (FY25)
52-week high / low
₹12.75 / ₹3.93 (20 Nov 2026)
1-year return
-64.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: GIANLIFE

Incorporated in 2018, Gian Lifecare Ltd is in the business of independent diagnostic/pathological laboratories

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.